These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9064351)

  • 1. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.
    Mandelboim O; Reyburn HT; Valés-Gómez M; Pazmany L; Colonna M; Borsellino G; Strominger JL
    J Exp Med; 1996 Sep; 184(3):913-22. PubMed ID: 9064351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self and viral peptides can initiate lysis by autologous natural killer cells.
    Mandelboim O; Wilson SB; Valés-Gómez M; Reyburn HT; Strominger JL
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4604-9. PubMed ID: 9114037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.
    Hölzemer A; Garcia-Beltran WF; Altfeld M
    Front Immunol; 2017; 8():1496. PubMed ID: 29184550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-C: An Accomplice in Rheumatic Diseases.
    Siegel RJ; Bridges SL; Ahmed S
    ACR Open Rheumatol; 2019 Nov; 1(9):571-579. PubMed ID: 31777841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-Independent Turnover of Human Leukocyte Antigen (HLA) Class Ia Molecules.
    Prevosto C; Usmani MF; McDonald S; Gumienny AM; Key T; Goodman RS; Gaston JS; Deery MJ; Busch R
    PLoS One; 2016; 11(8):e0161011. PubMed ID: 27529174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Structural Basis for Recognition of Human Leukocyte Antigen Class I Molecules by the Pan-HLA Antibody W6/32.
    Pymm P; Saunders PM; Anand S; MacLachlan BJ; Faoro C; Hitchen C; Rossjohn J; Brooks AG; Vivian JP
    J Immunol; 2024 Sep; 213(6):876-885. PubMed ID: 39093013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal-Fetal Compatibility in Recurrent Pregnancy Loss.
    Cuadrado-Torroglosa I; García-Velasco JA; Alecsandru D
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor KIR2DL1 Allelic Polymorphism Influences Posthematopoietic Progenitor Cell Transplantation Outcomes in the T Cell Depleted and Reduced Intensity Conditioning Setting.
    Wright PA; van de Pasch LAL; Dignan FL; Kichula KM; Pollock NR; Norman PJ; Marchan E; Hill L; Vandelbosch S; Fullwood C; Sheldon S; Hampson L; Tholouli E; Poulton KV
    Transplant Cell Ther; 2024 May; 30(5):488.e1-488.e15. PubMed ID: 38369017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
    Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C
    Front Immunol; 2022; 13():922252. PubMed ID: 35911762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killer Timing: The Temporal Uterine Natural Killer Cell Differentiation Pathway and Implications for Female Reproductive Health.
    Fraser R; Zenclussen AC
    Front Endocrinol (Lausanne); 2022; 13():904744. PubMed ID: 35832424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of KIR
    Meazza R; Falco M; Canevali P; Loiacono F; Colomar-Carando N; Muntasell A; Rea A; Mingari MC; Locatelli F; Moretta L; Lopez-Botet M; Pende D
    HLA; 2022 Aug; 100(2):119-132. PubMed ID: 35439359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing role of natural killer cells in cancer metastasis.
    Chan IS; Ewald AJ
    J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35289318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIR in Allogeneic Hematopoietic Stem Cell Transplantation: Need for a Unified Paradigm for Donor Selection.
    Dhuyser A; Aarnink A; Pérès M; Jayaraman J; Nemat-Gorgani N; Rubio MT; Trowsdale J; Traherne J
    Front Immunol; 2022; 13():821533. PubMed ID: 35242134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity.
    Vollmers S; Lobermeyer A; Körner C
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients.
    Gimeno L; González-Lozano I; Soto-Ramírez MF; Martínez-Sánchez MV; López-Cubillana P; Fuster JL; Martínez-García J; Martínez-Escribano J; Campillo JA; Pons-Fuster E; Ferri B; López-Abad A; Muro M; Minguela A
    Oncoimmunology; 2021; 10(1):1986943. PubMed ID: 34676148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the biology of KIR2DL3
    David G; Willem C; Legrand N; Djaoud Z; Mérieau P; Walencik A; Guillaume T; Gagne K; Chevallier P; Retière C
    Sci Rep; 2021 Aug; 11(1):15782. PubMed ID: 34349169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.
    Duygu B; Olieslagers TI; Groeneweg M; Voorter CEM; Wieten L
    Front Immunol; 2021; 12():680480. PubMed ID: 34295330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic mRNA expression of donor-derived activating KIR genes and their significant effects on clinical outcome after haematopoietic stem cell transplantation.
    Li Y; Wang T; Hu X; Zhang H; Bao X; Wu D; He J
    Clin Exp Immunol; 2021 Sep; 205(3):417-428. PubMed ID: 34085290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of NK Cell Receptor Ligands on Leukemic Cells Is Associated with the Outcome of Childhood Acute Leukemia.
    Martínez-Sánchez MV; Fuster JL; Campillo JA; Galera AM; Bermúdez-Cortés M; Llinares ME; Ramos-Elbal E; Pascual-Gázquez JF; Fita AM; Martínez-Banaclocha H; Galián JA; Gimeno L; Muro M; Minguela A
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human cytomegalovirus protein UL147A downregulates the most prevalent MICA allele: MICA*008, to evade NK cell-mediated killing.
    Seidel E; Dassa L; Schuler C; Oiknine-Djian E; Wolf DG; Le-Trilling VTK; Mandelboim O
    PLoS Pathog; 2021 May; 17(5):e1008807. PubMed ID: 33939764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.